José A de la Peña-Celaya, Jocelyn Aguilar-Luevano, Luisa Ma Alcivar-Cedeño, José L Álvarez-Vera, Irene Anaya-Cuellar, Erika Añorve-Hernández, Luara L Arana-Luna, Luis Arteaga-Ortíz, Pamela E Báez-Islas, Luisa I Banda-García, Ramón A Bates-Martín, Dafne Itzel Campa-Monroy, Mariela Cardiel-Silva, Ángel de Jesús Castillo-Salas, Xóchitl Cota-Rangel, Guillermo Díaz-Vargas, M Eugenia Espitia-Ríos, Patricia Estrada-Domínguez, Denisse Fermín-Caminero, Alinka García-Camacho, Carolina García-Castillo, Katheryn B Garzón-Velásquez, Carlos Gil-Rondero, Lidia V Guerra-Alarcón, Ana K Hernández-Colín, Eleazar Hernández-Ruiz, Areli E Hernández-Alcántara, Silvia A Hernández-Cervantes, Wilfrido Herrera-Olivares, Gregorio Ignacio-Ibarra, Sergio I Inclán-Alarcón, Faustino Leyto-Cruz, Juan P Macías-Flores, Andrea Martínez-de la Vega, Mario Alberto Martínez-Ramírez, Jorge Martínez-Coronel, Jesús Emanuel Medina-Coral, Lizeth Meza-Dávalos, Leire Montoya-Jiménez, Alba Morales-Hernández, Elizabeth Morales-López, Javier de Jesús Morales-Adrián, Maricruz Morales-de Azcué, Aldo Mújica-Martínez, Juan L Murillo-Cruz, Jéssica Nájera-Martínez, Iris Mabel Narváez-Sarmiento, Lorena Nava-Villegas, Marco A Nava-Alpide, Juan J Orellana Garibay, Ma Teresa Palafox-Zaldívar, Orlando G Palma-Moreno, Eugenia P Paredes-Lozano, Ma Luisa Pedraza-Colín, Juan M Pérez-Zúñiga, Alejandra B Pérez-Lizardi, Flavio Rojas-Castillejos, Eduardo Romero-Martínez, Hilda Romero-Rodelo, Josué Ruiz-Contreras, Azucena Saavedra-González, Erick Saucedo-Montes, Luis G Silva-Michel, Karina Silva-Vera, Óscar Teomitzi-Sánchez, Fredy Tepepa-Flores, Yanet Ventura-Enríquez, Atenas Villela-Peña, Shendel P Vilchis-González, Nidia Zapata-Canto, Pedro A Zárate-Rodríguez, Martha Alvarado-Ibarra
To identify this increasingly common pathology, known as multiple myeloma (MM), it is necessary to refer to the specific factors that characterize it; to this end, the classic criteria known as CRAB (hyperkalemia, renal failure, anemia, and lytic lesions) are available, in which renal failure is one of the most frequent complications. Recently, three indisputable biomarkers have been described for the diagnostic support for MM, which are: more than 10% of clonal plasma cells in bone marrow or, a biopsy that corroborates the presence of a plasmacytoma, light chain ratio ≥ 100 mg/dL and more than one focal lesion on magnetic resonance imaging...
2020: Gaceta Médica de México